TB
Terremoto Biosciences, Inc.
SEC filingBiotechnology · South San Francisco, CA
Amount raised$40.7Msold at filing
Total offering$108.6M$67.9M still open
Investors in the raise14count reported to the SEC
FiledApr 22, 2026first sale Apr 10, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Michael GollerDirector
Grace LuExecutive Officer
James ChristensenExecutive Officer, Director
Reid HuberDirector
Peter ThompsonDirector
Daniel O'ConnellDirector
Charles BaumExecutive Officer, Director
Executive officers, directors and promoters as listed on the Form D.